Digital health innovations are helping achieve a long-sought-after healthcare industry objective: cutting healthcare costs while improving patient outcomes simultaneously—an outcome that is especially important given the impact of the COVID-19 pandemic. By decisively selecting which value pools and strategies to prioritize, healthcare investors and companies can effectively thrive in the fast-growing digital health space and improve healthcare for patients worldwide.
Hannah Devlin, Guardian UK Science Correspondent, reports that two US patients have recovered from intractable infections after being treated with a pioneering phage therapy involving genetically engineered bacteria-killing viruses.A 26-year-old man with cystic fibrosis, was approaching death after suffering a chronic lung infection. After being given the phage therapy, his infection cleared allowing him to receive a lung transplant and resume an active life.And, a 56-year-old man with severe arthritis, showed a remarkable recovery from a skin infection that was taking hold of his body and which had proved untreatable with conventional drugs. For more information see: https://www.inkl.com/news/phage-